ARCHIVES

“Spoiled, Petulant Brat”: BioMarin CEO Fires Off Feisty Emails In Battle Over Access to PARP Inhibitor

This article is from The Cancer Letter archive.

Vol. 39 No. 42 | November 8, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Stand Up To Cancer Canada to Fund Two Dream Teams

October 17, 2014

Finasteride Could Save Many Years Of Life If Widely Used For Prostate Cancer Prevention

February 25, 2005

DCCP Board Gives Concept Approval To RFA For Biochemical Epidemiolgy, New And Recompeting Contract Program

September 23, 1983

In Brief: Jordan To Join MD Anderson Cancer Center

July 25, 2014

In a letter, ASCO reaffirms its views on oncology consolidation at FDA.

July 9, 2004

CDC Warns Burton Patients Of Risk Of HTLV-3 Infection

August 16, 1985